Nevertheless, current evidence supports GLP-1 RAs and multi-agonist formulations as highly promising pharmacotherapies that address the complex, multifactorial pathophysiology of MASLD while simultaneously improving cardiometabolic comorbidities, positioning them as cornerstone treatments in the evolving therapeutic landscape for this prevalent and burdensome disease
GLP-1 agonists can help with that
Abbasi Hormozi S, Kouhkan A, Shahverdi A, Vesali S, Parhizkar A, Abbasihormozi SH
In SURMOUNT-OSA, adults on tirzepatide saw reductions in apnea-hypopnea index (AHI) of up to 62.8% and disease resolution rates of 43.0% to 51.5%
But during flare-ups, reducing your intake of these foods can help reduce or eliminate the burps
This commenter also recommended that median values could be statistically calculated with two claims or greater